These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

748 related items for PubMed ID: 28444549

  • 1. Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.
    Sabbah M, Kadota K, El-Eraky A, Kamal HM, Abdellah AT, El Hawary A.
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1463-1472. PubMed ID: 28444549
    [Abstract] [Full Text] [Related]

  • 2. In-stent neoatherosclerosis and tissue characteristics of restenotic lesions following implantation of second generation drug-eluting stents in unrestricted coronary lesions: Optical frequency domain imaging study.
    Sabbah M, Kadota K, El-Eraky A, Kamal HM, Abdellah AT, El Hawary A.
    J Interv Cardiol; 2017 Jun; 30(3):195-203. PubMed ID: 28295660
    [Abstract] [Full Text] [Related]

  • 3. Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents.
    Song L, Mintz GS, Yin D, Yamamoto MH, Chin CY, Matsumura M, Fall K, Kirtane AJ, Parikh MA, Moses JW, Ali ZA, Shlofmitz RA, Maehara A.
    Int J Cardiovasc Imaging; 2017 Aug; 33(8):1115-1124. PubMed ID: 28281026
    [Abstract] [Full Text] [Related]

  • 4. Comparison of vascular responses after different types of second-generation drug-eluting stents implantation detected by optical coherence tomography.
    Ohtani H, Kimura S, Sugiyama T, Hishikari K, Misawa T, Mizusawa M, Hayasaka K, Yamakami Y, Kojima K, Sagawa Y, Hikita H, Ashikaga T, Takahashi A, Isobe M.
    Int J Cardiovasc Imaging; 2017 Feb; 33(2):177-186. PubMed ID: 27761750
    [Abstract] [Full Text] [Related]

  • 5. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.
    Lee SY, Hur SH, Lee SG, Kim SW, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001878. PubMed ID: 25613674
    [Abstract] [Full Text] [Related]

  • 6. Impact of optical coherence tomography-derived neointimal tissue morphology on development of very late in-stent restenosis.
    Fujii K, Otsuji S, Yamamoto W, Takiuchi S, Ishibuchi K, Tamaru H, Kakishita M, Ibuki M, Hasegawa K, Ishii R, Nakabayashi S, Higashino Y.
    Catheter Cardiovasc Interv; 2020 Oct 01; 96(4):E398-E405. PubMed ID: 32077557
    [Abstract] [Full Text] [Related]

  • 7. Very early neointimal coverage of new biodegradable polymer drug-eluting stent compared with durable polymer everolimus-eluting stent evaluated by optical frequency domain imaging.
    Kobayashi N, Ito Y, Yamawaki M, Araki M, Sakai T, Sakamoto Y, Mori S, Tsutsumi M, Nauchi M, Honda Y, Tokuda T, Makino K, Shirai S, Hirano K.
    Int J Cardiovasc Imaging; 2018 Apr 01; 34(4):515-522. PubMed ID: 29159531
    [Abstract] [Full Text] [Related]

  • 8. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Rittger H, Wöhrle J, Brachmann J, Hohenforst-Schmidt W, Schlundt C, Lonke S, von Cranach M, Markovic S, Achenbach S, Waliszewski M.
    Catheter Cardiovasc Interv; 2016 Oct 01; 88(4):529-534. PubMed ID: 26893095
    [Abstract] [Full Text] [Related]

  • 9. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
    Alfonso F, Pérez-Vizcayno MJ, García Del Blanco B, García-Touchard A, López-Mínguez JR, Masotti M, Zueco J, Melgares R, Mainar V, Moreno R, Domínguez A, Sanchís J, Bethencourt A, Moreu J, Cequier A, Martí V, Otaegui I, Bastante T, Gonzalo N, Jiménez-Quevedo P, Cárdenas A, Fernández C, under the auspices of the Interventional Cardiology Working Group of the Spanish Society of Cardiology.
    Circ Cardiovasc Interv; 2016 Jul 01; 9(7):. PubMed ID: 27412868
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of Early Healing Profile and Neointimal Transformation Over 24 Months Using Longitudinal Sequential Optical Coherence Tomography Assessments and 3-Year Clinical Results of the New Dual-Therapy Endothelial Progenitor Cell Capturing Sirolimus-Eluting Combo Stent: The EGO-Combo Study.
    Lee SW, Lam SC, Tam FC, Chan KK, Shea CP, Kong SL, Wong AY, Yung A, Zhang LW, Tse HF, Wu KK, Chan R, Haude M, Mehran R, Mintz GS, Maehara A.
    Circ Cardiovasc Interv; 2016 Jul 01; 9(7):. PubMed ID: 27418609
    [Abstract] [Full Text] [Related]

  • 11. [Analysis of optical coherence tomography of early and very late stent restenosis after drug-eluting stent implantation].
    Liu ZJ, Shi B, Deng CC, Xu GX, Zhao RZ, Shen CY, Wang ZL, Liu HL.
    Zhonghua Yi Xue Za Zhi; 2017 Jun 20; 97(23):1778-1783. PubMed ID: 28647998
    [Abstract] [Full Text] [Related]

  • 12. Optical coherence tomography characteristics of in-stent restenosis after drug-eluting stent implantation: a novel classification and its clinical significance.
    Yamamoto W, Fujii K, Otsuji S, Takiuchi S, Kakishita M, Ibuki M, Hasegawa K, Ishibuchi K, Tamaru H, Yasuda S, Ishii R, Nakabayashi S, Kusumoto H, Higashino Y.
    Heart Vessels; 2020 Jan 20; 35(1):38-45. PubMed ID: 31250131
    [Abstract] [Full Text] [Related]

  • 13. Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study.
    Stettler R, Dijkstra J, Räber L, Torii R, Zhang YJ, Karanasos A, Lui S, Crake T, Hamshere S, Garcia-Garcia HM, Tenekecioglu E, Ozkor M, Windecker S, Serruys PW, Regar E, Mathur A, Bourantas CV.
    EuroIntervention; 2018 Feb 02; 13(15):e1831-e1840. PubMed ID: 28606888
    [Abstract] [Full Text] [Related]

  • 14. The wound healing response after implantation of a drug-eluting stent is impaired persistently in the long term.
    Nasuno T, Tokura M, Kageyama M, Toyoda S, Sakuma M, Komatsu T, Taguchi I, Abe S, Inoue T.
    Heart Vessels; 2016 Jun 02; 31(6):985-9. PubMed ID: 25939630
    [Abstract] [Full Text] [Related]

  • 15. Characterization of in-stent neointimal tissue components following drug-eluting stent implantation according to the phase of restenosis using a 40-MHz intravascular ultrasound imaging system.
    Araki T, Nakamura M, Sugi K.
    J Cardiol; 2014 Dec 02; 64(6):423-9. PubMed ID: 24794755
    [Abstract] [Full Text] [Related]

  • 16. Randomized comparison of acute stent malapposition between platinum-chromium versus cobalt-chromium everolimus-eluting stents.
    Kim BK, Shin DH, Kim JS, Ko YG, Choi D, Jang Y, Hong MK.
    Int J Cardiovasc Imaging; 2015 Feb 02; 31(2):269-77. PubMed ID: 25345751
    [Abstract] [Full Text] [Related]

  • 17. In-stent restenosis assessed with frequency domain optical coherence tomography shows smooth coronary arterial healing process in second-generation drug-eluting stents.
    Kajiya T, Yamaguchi H, Takaoka J, Fukunaga K, Arima R, Miyamura A, Ninomiya T, Atsuchi N, Atsuchi Y, Terashima M, Kaneda H, Ohishi M.
    Singapore Med J; 2019 Jan 02; 60(1):48-51. PubMed ID: 29632955
    [Abstract] [Full Text] [Related]

  • 18. Neoatherosclerosis in Patients With Coronary Stent Thrombosis: Findings From Optical Coherence Tomography Imaging (A Report of the PRESTIGE Consortium).
    Joner M, Koppara T, Byrne RA, Castellanos MI, Lewerich J, Novotny J, Guagliumi G, Xhepa E, Adriaenssens T, Godschalk TC, Malik N, Alfonso F, Tada T, Neumann FJ, Desmet W, Ten Berg JM, Gershlick AH, Feldman LJ, Massberg S, Kastrati A, Prevention of PRESTIGE Investigators.
    JACC Cardiovasc Interv; 2018 Jul 23; 11(14):1340-1350. PubMed ID: 30025727
    [Abstract] [Full Text] [Related]

  • 19. Association between asymmetric dimethylarginine and in-stent restenosis tissue characteristics assessed by optical coherence tomography.
    Huang WC, Teng HI, Chen HY, Wu CJ, Tsai CT, Hsueh CH, Chen YY, Hau WK, Lu TM.
    Int J Cardiol; 2019 Aug 15; 289():131-137. PubMed ID: 31079970
    [Abstract] [Full Text] [Related]

  • 20. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus-, and sirolimus-eluting stent implantation.
    Song HG, Kang SJ, Ahn JM, Kim WJ, Lee JY, Park DW, Lee SW, Kim YH, Lee CW, Park SW, Park SJ.
    Catheter Cardiovasc Interv; 2014 May 01; 83(6):873-8. PubMed ID: 22815193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.